The three-year commitment will help reduce health disparities by enabling easier access to prostate and colorectal cancer education, screening and treatment support.
Eligible patients are now enrolling in phase 1 studies, receiving an advanced level of care that positions Mary Bird Perkins in a new, elite category of cancer centers.